Grow Your Pharma Business Digitally
J&J declares historic success as Invokana comes through in PhIII CKD trial
NICE guideline to address variation in provisions for adults with CP
Pliant banks a $62M round to fuel their shot at fibrosis targets
Purdue uses FDA authority to defend against opioid suit
Guardian Pharmacy Services Secures $60 Million to Fuel Expansion
Sobi launches Kineret for AOSD, SJIA
China pushes for lower cancer drug prices: Xinhua
Pfizer, Astellas’ Xtandi grabs key nod in nonmetastatic cancer
Juul e-cigarette expands to England and Scotland, eyes Asia
Horizon Pharma Announces USPTO Issuance Covering Ravicti Oral Liquid
A unicorn joins this week’s stampede of biotechs into the red-hot Nasdaq casin...
Aurobindo to acquire Apotex's biz in European countries
Vant commander Ramaswamy heads back to Nasdaq with $150M pitch
NICE backs AZ’ asthma biologic Fasenra
New SR Exendin-4 Formulation proves effective against Parkinson's
Authorised products containing valsartan as active substance: Overview
China vaccine producer under investigation
Otezla® (apremilast): Celgene Corporation v. Pharmascience Inc.
Revlimid® (Lenalidomide): Celgene Corporation v. Lotus Pharmaceutical Co., Alv...
Cialis® (tadalafil): Eli Lilly, ICOS Corporation v. Torrent Pharma Ltd. et al
Copyright © 2017 LePro PharmaCompass OPC Private Limited, All rights reserved.